Tag: Mirabegron (Myrbetriq) Manufacturing Plant Project

Introduction Mirabegron, marketed under the brand name Myrbetriq, is a medication primarily used for the treatment of overactive bladder (OAB). It is a β3-adrenergic agonist that works by relaxing the bladder muscles, thereby increasing bladder capacity and reducing the frequency of urination. The global demand for OAB medications has surged with the increasing prevalence of the condition, especially among aging populations and those with underlying health issues like diabetes. Establishing a Mirabegron (Myrbetriq) manufacturing plant is an excellent opportunity to tap into the growing pharmaceutical market, specifically in the urology…